Researchers at Stanford University have developed an intranasal vaccine that reportedly protected mice for at least three months against multiple respiratory pathogens — including SARS-CoV-2, other coronaviruses, bacterial infections like Staphylococcus aureus and Acinetobacter baumannii, and allergens like house dust mites.
Stanford Tests 'Universal Vaccine' Against Multiple Respiratory Pathogens